Sacrosidase: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Sacrosidase. Educational only — not medical advice.
Labeled uses
Sucraid ® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.
Source: FDA labeling via NIH DailyMed (set d613bb7f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.